Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-22 Sale | 2026-01-26 4:33 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 1,882 | $18.15 | $34,162 | 210,817 (Direct) | View |
| 2025-12-22 Sale | 2025-12-23 4:02 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 9,200 | $18.31 | $168,492 | 234,339 (Direct) | View |
| 2025-11-21 Sale | 2025-11-25 6:42 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 18,400 | $18.54 | $341,074 | 359,518 (Direct) | View |
| 2025-10-09 Sale | 2025-10-10 5:22 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 6,415 | $18.23 | $116,931 | 261,939 (Direct) | View |
| 2025-10-06 Sale | 2025-10-08 5:33 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 30,385 | $18.21 | $553,198 | 543,850 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-02 Option Award | 2026-02-04 4:35 pm | N/A 2036-02-02 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2026-01-22 Exercise | 2026-01-26 4:33 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 1,882 | $3.7898 | 210,817 (Direct) | View |
| 2026-01-22 Exercise | 2026-01-26 4:33 pm | N/A 2033-04-05 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 1,882 | $0 | 210,817 (Direct) | View |
| 2025-12-22 Exercise | 2025-12-23 4:02 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 9,200 | $3.7898 | 234,339 (Direct) | View |
| 2025-12-22 Exercise | 2025-12-23 4:02 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 9,200 | $0 | 234,339 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-25 6:42 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 18,400 | $3.7898 | 359,518 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-25 6:42 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 18,400 | $0 | 359,518 (Direct) | View |
| 2025-10-09 Exercise | 2025-10-10 5:22 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 6,415 | $3.7898 | 261,939 (Direct) | View |
| 2025-10-09 Exercise | 2025-10-10 5:22 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 6,415 | $0 | 261,939 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 5:33 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 30,385 | $3.7898 | 543,850 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 5:33 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 30,385 | $0 | 543,850 (Direct) | View |
Ownership | 2024-09-12 9:19 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 0 | $0 | 1,103,415 (Direct) | View |